Home Tags AstraZeneca

Tag: AstraZeneca

AstraZeneca

AstraZeneca Closes Mega $39B Alexion Buyout

AstraZeneca’s mega $39 billion takeover of Alexion Pharmaceuticals has come to a close, delivering the British pharma a lucrative portfolio of immunology medicines and...
Astrazeneca

AstraZeneca Clears Final UK Antitrust Hurdle

Wednesday, July 14, AstraZeneca (AZ) announced that the UK’s Competition and Markets Authority (CMA) has cleared the Alexion buyout without raising any antitrust concerns. The...
Astrazeneca

EU Clears AstraZeneca’s Acquisition Of Alexion

The European Commission has cleared AstraZeneca’s (AZ) proposed acquisition of rare disease specialist Alexion, initially announced in December 2020. Last year, AZ revealed its plans...
AstraZeneca

UK & EU Antitrust Regulators Concerned Over AstraZeneca’s $39B Alexion Buy

EU & UK antitrust watchdogs are set to decide by this weekend whether to approve AstraZeneca’s US$39 billion bid for biopharmaceutical company Alexion, a...
Astrazeneca

AstraZeneca $39B Alexion Buy Hits UK Antitrust Roadblock

On Tuesday, the UK’s Competition and Markets Authority (CMA) announced that it has launched an anti-competition investigation into the AstraZeneca-Alexion deal. The agency wonders whether...
AstraZeneca

AstraZeneca’s $39B Alexion Buy Clears FTC Review

AstraZeneca is one step closer to acquiring Alexion Pharmaceuticals having been cleared by the US Federal Trade Commission after an antitrust review, the company...
AstraZeneca

AstraZeneca Delays FTC Review For $39B Alexion Deal

AstraZeneca is resetting the clock to give the Federal Trade Commission more time to review its roughly US$39 billion bid for Alexion Pharmaceuticals, the...
AstraZeneca

AstraZeneca To Buy Alexion For $39 Billion

Leading COVID-19 vaccine developer AstraZeneca agreed on Saturday, December 12, to buy Boston pharmaceutical firm Alexion for US$39 billion, reported The Wall Street Journal. The...

SEP-10(2)

In this issue: This issue contains a special bonus, but first we take a look at two recent EU court decisions. Kent Bernard, Sean-Paul Brankin,...

The AZ Judgment: A Green Light for Further Action on Pharma...

Sean-Paul Brankin, Sep 30, 2010 On July 1, 2010, the General Court issued its long awaited judgment in AstraZeneca v Commission, almost five years after...
Enable Notifications    OK No thanks